InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference Call to Discuss Q1 2022 Results, Provide Drug Development Update
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with unmet medical needs, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on May 12, 2022, to discuss its results for the first quarter and provide an update on its clinical pipeline. Interested parties may join the…